C10: Controversies in the Management of Asymptomatic Severe Carotid Stenosis

Thursday, June 5, 2025

3:30 PM – 5:00 PM CT

Location: Morial CC, Second Floor, Room 208-210

Moderator(s)

Ali AbuRahma, MD

Professor of Surgery
WVU/Charleston Area Medical Center
Charleston, West Virginia
Raghu Motaganahalli, MD

Professor of Surgery
Division of Vascular Surgery, Indiana University School of Medicine, Indianapolis, IN, USA
Indianapolis, Indiana

Presentations:

3:30 PM – 3:33 PM CT

Introduction to the Controversies of Treating Asymptomatic Carotid Stenosis
Speaker: Ali F. AbuRahma, MD – WVU/Charleston Area Medical Center
3:33 PM – 3:41 PM CT

CEA Should be the First Line of Therapy in a Standard Risk Patient
Speaker: Bruce A. Perler, MD, MBA – Johns Hopkins Hospital
3:41 PM – 3:49 PM CT

TCAR Should be the First Line of Therapy in Standard Risk Patients
Speaker: Marc L. Schermerhorn, MD – Beth Israel Deaconess Medical Center
3:49 PM – 3:57 PM CT

TFCAS Should be the First Line of Therapy in Standard Risk Patients
Speaker: Peter A. Schneider, MD – Division of Vascular and Endovascular Surgery, University of California, San Francisco, San Francisco, CA, USA
3:57 PM – 4:05 PM CT

Status of CREST 2 and Role of Best Medical Therapy in Standard Risk Patients
Speaker: Brajesh Lal, MD
4:05 PM – 4:13 PM CT

CEA Should be the First Line of Therapy in a High-Risk Patients
Speaker: Wei Zhou, MD – University of Arizona
4:13 PM – 4:21 PM CT

TCAR Should be the First Line of Therapy in a High-Risk Patients
Speaker: Caitlin W. Hicks, MD, MS (she/her/hers) – Johns Hopkins Hospital
4:21 PM – 4:29 PM CT

TFCAS Should be the First Line of Therapy in a High-Risk Patients
Speaker: Sean P. Lyden, MD – Department of Vascular Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic
4:29 PM – 4:37 PM CT

Role of Carotid Intervention for Asymptomatic Carotid Stenosis in Female Population and Where it Differs
Speaker: Yana Etkin, MD – Zucker School of Medicine at Hofstra/Northwell
4:37 PM – 5:00 PM CT

Panel Discussion